Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedBanner notice informs users about a lapse in government funding and that the NIH Clinical Center is open, with status updates available at opm.gov. Site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check13 days agoChange DetectedAdministrative UI and metadata updates were made to the study page, including showing a glossary, updating QC-related labels to 'Last Update Submitted that Met QC Criteria', and adding a revision tag (v3.4.0). These changes do not affect the core study details or results, and the page's key information remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows a minor revision update (v3.3.4 added, v3.3.3 removed) that does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a Locations section including Beijing Municipality and updated the page revision to v3.3.3. Removed the Beijing Municipality Locations subsection and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check77 days agoChange DetectedPublications section now notes that PubMed-derived publications may not be about the study, and the Revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page removed a general government funding/operating status notice, and this change does not affect the study details, eligibility criteria, outcomes, or participation information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.